(Q74079941)

English

Oral (1-->3),(1-->4)-beta-D-glucan synergizes with antiganglioside GD2 monoclonal antibody 3F8 in the therapy of neuroblastoma

scientific article published on 01 May 2002

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12006541

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12006541%20AND%20SRC:MED&resulttype=core&format=json

retrieved

8 November 2019

title

Oral (1-->3),(1-->4)-beta-D-glucan synergizes with antiganglioside GD2 monoclonal antibody 3F8 in the therapy of neuroblastoma (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12006541

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12006541%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

1 reference

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12006541

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12006541%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1

Nai-Kong V Cheung

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12006541

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12006541%20AND%20SRC:MED&resulttype=core&format=json

retrieved

8 November 2019

language of work or name

English

0 references

publication date

1 May 2002

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12006541

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12006541%20AND%20SRC:MED&resulttype=core&format=json

retrieved

8 November 2019

published in

Clinical Cancer Research

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12006541

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12006541%20AND%20SRC:MED&resulttype=core&format=json

retrieved

8 November 2019

volume

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12006541

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12006541%20AND%20SRC:MED&resulttype=core&format=json

retrieved

8 November 2019

issue

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12006541

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12006541%20AND%20SRC:MED&resulttype=core&format=json

retrieved

8 November 2019

page(s)

1217-1223

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12006541

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12006541%20AND%20SRC:MED&resulttype=core&format=json

retrieved

8 November 2019

Identifiers

PubMed publication ID

12006541

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12006541

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12006541%20AND%20SRC:MED&resulttype=core&format=json

(Q74079941)

Oral (1-->3),(1-->4)-beta-D-glucan synergizes with antiganglioside GD2 monoclonal antibody 3F8 in the therapy of neuroblastoma

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)